Transdermal therapy in Parkinson's disease

Lancet Neurology

Volumn 6, Issue 6, 2007, Pages 475-476

  Korczyn, Amos D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; LISURIDE; PRAMIPEXOLE; RASAGILINE; ROTIGOTINE; SELEGILINE;

BRAIN DYSFUNCTION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DYSARTHRIA; DYSKINESIA; GAIT DISORDER; HUMAN; IMPULSE CONTROL DISORDER; LETTER; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE;

ADMINISTRATION, CUTANEOUS; DOPAMINE AGONISTS; HUMANS; PARKINSON DISEASE; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 34248396407     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70114-X     Document Type: Letter

References (10)

1. Korczyn A. Pathophysiology of drug-induced dyskinesias. Neuropharmacology 11 (1972) 601-607
2. Rabey J., Nissipeanu P., Inzelberg R., and Korczyn A. Beneficial effect of cabergoline, a new long-lasting D2 agonist in the treatment of Parkinson's disease. Clin Neuropharmacol 17 (1994) 286-293
3. Olanow C., Obeso J., and Stocchi F. Drug insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nat Clin Prac Neurol 2 (2006) 382-392
4. Rascol O., Brooks D., Korczyn A., De Deyn P., Clarke C., and Lang A. A five year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 342 (2000) 1484-1491
5. The Parkinson Study Group. A controlled trial of rotigotine monotherapy in early Parkinson's disease. Arch Neurol 60 (2003) 1721-1728
6. Watts R., Jankovic J., Waters C., Rajput A., Boroojerdi B., and Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson's disease. Neurology 68 (2007) 272-276
7. Poewe W., Rascol O., Quinn N., et al., on behalf of the Sp515 investigators. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurology 6 (2007) 513-520
8. Waters C., Kapil D., Hauser R., Molho E., and Bertoni J. Zydis selegiline reduces off-time in Parkinson's disease patients with motor fluctuations: a 3 month, randomized, placebo-controlled study. Mov Disord 19 (2004) 426-432
9. The Parkinson Study Group. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson's disease and motor fluctuations. Arch Neurol 62 (2005) 241-248
10. Tippmann-Peikert M., Park J., Boeve B., Shepard J., and Silber M. Pathologic gambling in patients with restless legs syndrome treated with dopminergic agonists. Neurology 68 (2007) 301-303